Sudden Hearing Loss Presentation
Patient reports acute onset hearing loss. Definition: ≥30dB hearing loss in ≥3 consecutive frequencies occurring within ≤72 hours.
Sudden Sensorineural Hearing Loss (AAO-HNSF 2019): Sudden Hearing Loss Presentation → Distinguish SNHL from Conductive → Urgent Audiometry → Identifiabl...
Pathway Overview
14 steps
14 total
Patient reports acute onset hearing loss. Definition: ≥30dB hearing loss in ≥3 consecutive frequencies occurring within ≤72 hours.
KAS 1 (Strong): Perform Weber/Rinne tests. SNHL: Weber lateralizes to GOOD ear, Rinne positive bilaterally. Conductive: Weber to affected ear, Rinne negative affected side.
Obtain audiogram within 14 days of symptom onset (ideally immediately). Documents degree and configuration of hearing loss. Establishes baseline for monitoring.
History and exam to exclude: Ototoxic drugs, Meniere's disease, acoustic neuroma, stroke, trauma, infection (otitis, meningitis), autoimmune disease.
If identifiable cause found: treat accordingly. This algorithm focuses on IDIOPATHIC SSNHL. Stroke protocol if neurological signs.
Consider MRI with gadolinium to evaluate for retrocochlear pathology (acoustic neuroma). Especially if: asymmetric hearing, unilateral tinnitus, focal neurological signs.
Offer oral corticosteroids as initial therapy (Option, may offer). Typical: Prednisone 1mg/kg/day (max 60mg) x 10-14 days with taper. OR Dexamethasone 10mg x 7 days. Start within 2 weeks of onset.
Reassess hearing at 2-6 weeks. Complete recovery? Partial recovery? No recovery?
If hearing recovers fully, routine follow-up with audiometry. Counsel on hearing protection. No specific restrictions.
KAS: Offer intratympanic steroids 2-6 weeks after symptom onset for incomplete recovery. Dexamethasone 10-24mg/mL or methylprednisolone 40mg/mL. 3-4 injections over 2 weeks.
KAS 13 (Strong): Counsel on audiologic rehabilitation: hearing aids, CROS/BiCROS, cochlear implant evaluation if profound. Tinnitus management. Support groups.
Hyperbaric oxygen therapy within 2 weeks of onset (in combination with steroids) OR as salvage within 1 month. 10-20 sessions at 2.0-2.5 ATA for 90 minutes.
KAS 7 (Strong): Educate on natural history (1/3 recover, 1/3 partial, 1/3 permanent). Discuss treatment limitations. Address tinnitus if present.
KAS: Do NOT order routine CT head (strong against). Do NOT order routine labs (strong against). Do NOT prescribe antivirals, thrombolytics, vasodilators (strong against).
AAO-HNSF Clinical Practice Guideline: Sudden Hearing Loss (Update)
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
Applicable Regions
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
The Sudden Sensorineural Hearing Loss (AAO-HNSF 2019) is a emergency clinical algorithm for Otolaryngology. It provides a structured decision tree to guide clinical decision-making, based on AAO-HNSF Clinical Practice Guideline: Sudden Hearing Loss (Update).
This algorithm is based on AAO-HNSF Clinical Practice Guideline: Sudden Hearing Loss (Update) (DOI: 10.1177/0194599819859885).
Known limitations include: Applies to adults ≥18 years only; Does not address pediatric SSNHL; Idiopathic SSNHL focus - excludes known causes; HBOT availability varies by region. Individual patient factors may require deviation from these recommendations.
In AttendMe.ai, the Sudden Sensorineural Hearing Loss (AAO-HNSF 2019) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free